NCT01495429

Brief Summary

The investigators aim to compare the complications between centrally and peripherally inserted central venous catheters in neurological intensive care unit patients. The study hypothesis is that peripherally inserted catheters will have more cumulative complications due to venous thrombosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2012

Typical duration for phase_3

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 20, 2011

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

August 4, 2015

Status Verified

August 1, 2015

Enrollment Period

3.5 years

First QC Date

December 13, 2011

Last Update Submit

August 3, 2015

Conditions

Keywords

catheter related large vein thrombosisupper extremity deep venous thrombosiscentral venous cathetersupper extremity catheter related large vein thrombosis

Outcome Measures

Primary Outcomes (1)

  • The composite of death or catheter related large vein thrombosis

    15 days

Secondary Outcomes (1)

  • Cumulative catheter related complications until discharge

    30 days

Study Arms (2)

PICC line (Peripherally)

EXPERIMENTAL

placement of a picc line

Procedure: Central venous catheter

CICVC (central insertion)

ACTIVE COMPARATOR

placement of a centrally inserted central venous catheter

Procedure: Central venous catheter

Interventions

Placement of a peripherally inserted central venous catheter

PICC line (Peripherally)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all patients age \> 18, admitted to the neurological ICU who are require a de novo central venous catheter as standard of care and in which a double lumen 5f PICC or CICVC (triple lumen, 7f) are acceptable for the indication.
  • the patients must be expected to survive and need a central venous catheter for at least 7 days.

You may not qualify if:

  • prisoner
  • age \< 18
  • expected to die or have care withdrawn prior to ICU day 7
  • requiring an emergent central venous catheter
  • suspected bacteremia
  • recent central venous catheter within the last 30 days
  • patients who are not a candidate for bedside placement of either a CICVC or PICC line
  • patients with renal insufficiency with creatinine level greater than 3.0 mg/dL (265.2 m mol/L) or who were undergoing hemodialysis
  • patients requiring a central venous catheter for prolonged antibiotic therapy\\
  • patient who the treating clinician feels clearly needs one particular type of catheter over the other

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Michigan Health System

Ann Arbor, Michigan, 48103, United States

Location

Bronson Methodist Hospital

Kalamazoo, Michigan, 49001, United States

Location

MeSH Terms

Conditions

Venous Thrombosis

Interventions

Central Venous Catheters

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Vascular Access DevicesCathetersEquipment and Supplies

Study Officials

  • Jeffrey J Fletcher, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study PI

Study Record Dates

First Submitted

December 13, 2011

First Posted

December 20, 2011

Study Start

January 1, 2012

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

August 4, 2015

Record last verified: 2015-08

Locations